BlackRock Institutional Trust’s AMAG Pharmaceuticals AMAG Stock Holding History

BlackRock Institutional Trust’s Portfolio AMAG Stock Details AMAG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$32.7M	Buy	938,243 +70,697	+8%	+$2.11M	﹤0.01%	1610
2016 Q3	$21.3M	Sell	867,546 -35,543	-4%	-$888K	﹤0.01%	1852
2016 Q2	$21.6M	Buy	903,089 +1,651	+0.2%	+$37.9K	﹤0.01%	1799
2016 Q1	$21.1M	Buy	901,438 +216,514	+32%	+$5.14M	﹤0.01%	1794
2015 Q4	$20.7M	Buy	684,924 +102,758	+18%	+$3.32M	﹤0.01%	1839
2015 Q3	$23.1M	Hold	582,166	–	–	﹤0.01%	1738
2015 Q2	$40.2M	Sell	582,166 -36,976	-6%	-$2.33M	0.01%	1430
2015 Q1	$33.8M	Sell	619,142 -5,298	-0.8%	-$253K	0.01%	1576
2014 Q4	$26.6M	Sell	624,440 -51,014	-8%	-$1.84M	﹤0.01%	1720
2014 Q3	$21.6M	Sell	675,454 -159,817	-19%	-$3.41M	﹤0.01%	1822
2014 Q2	$17.3M	Sell	835,271 -18,025	-2%	-$333K	﹤0.01%	2060
2014 Q1	$16.5M	Sell	853,296 -474,412	-36%	-$10.1M	﹤0.01%	2089
2013 Q4	$32.2M	Buy	1,327,708 +649,829	+96%	+$15.3M	0.01%	1585
2013 Q3	$14.6M	Sell	677,879 -11,781	-2%	-$278K	﹤0.01%	2093
2013 Q2	$15.3M	Buy	+689,660	New	+$15.2M	﹤0.01%	2012

Other funds holding AMAG

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock Institutional Trust's AMAG Position: Q4 2016 in Review

BlackRock Institutional Trust increased its AMAG Pharmaceuticals (AMAG) stake by 8.1% in Q4 2016, buying an estimated $2.11M and bringing the position to 938,243 shares worth $32.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1610.

BlackRock Institutional Trust first reported a position in AMAG in Q2 2013 and has held it in 15 quarters since. The position peaked at $40.2M in Q2 2015. 206 funds tracked by Wall St. Rank hold AMAG as of Q4 2016.

BlackRock Institutional Trust held 938,243 shares of AMAG Pharmaceuticals worth $32.7M as of Q4 2016.
BlackRock Institutional Trust bought 70,697 AMAG Pharmaceuticals shares in Q4 2016, an estimated $2.11M.
AMAG Pharmaceuticals made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #1610 holding.
BlackRock Institutional Trust first reported a position in AMAG Pharmaceuticals in Q2 2013 and has held it in 15 quarters since.
BlackRock Institutional Trust's AMAG Pharmaceuticals position peaked at $40.2M in Q2 2015.
206 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.